
The FDA cleared Access MeMed BV, a host-response blood test that helps distinguish bacterial from viral infections in adults and children in as little as 15 minutes.
The first standalone at-home sample collection kit received FDA approval, new research shows children are not spared from COVID-19 risk, and 4 more snapshots of key pandemic coverage from May.






